Loading clinical trials...
Loading clinical trials...
First episode psychosis patients often experiences treatment delay. This reduces their prospects for recovery and makes unnecessary burdens for them and their carers. A better understanding of help se...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nordlandssykehuset HF
NCT05728138 · Self Harm, First Episode Psychosis
NCT06650943 · First Episode Psychosis (FEP), Metabolic Syndrome X
NCT04007510 · First Episode Psychosis (FEP)
NCT05509998 · First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR)
NCT04298450 · First Episode Psychosis, Psychosis, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions